𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection

✍ Scribed by Hong-Yuan Hsu; Mei-Hwei Chang; Chin-Yun Lee; Juei-San Chen; Hey-Chi Hsu; Ding-Shinn Chen


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
559 KB
Volume
15
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Spontaneous loss of HBsAg is infrequent in adult HBV carriers. Little is known about this serological change in children. In a prospective study of 420 hepatitis B virus-carrier children who were observed for 1 to 12 yr (mean = 4.3 yr), spontaneous loss of HBsAg occurred in 10 patients, with an average incidence of 0.6%/yr. The HBsAg clearance rate was significantly higher in children who had anti-HBe; children who were at an older age on entry; children whose mothers were HBsAg-; or children with severe liver histological changes detected while they were HBeAg+ . Children who seroconverted from HBeAg to anti-HBe before the age of 6 or who had a peak serum ALT level above 100 IU/L were more likely to clear HBsAg. In all 10 patients who became HBsAg-, serum hepatitis B virus DNA became undetectable by both spot hybridization and the polymerase chain reaction, suggesting a complete clearance of the v i r u s from serum. After the loss of HBsAg, the anti-HBs levels were higher in the children born to carrier mothers than in those born to noncarrier mothers. These findings suggest that chronic hepatitis B virus-carrier children rarely lose HBsAg, especially if they have been infected during the perinatal period and have mild histological changes. The poor humoral immune response to HBsAg may be a contributing factor in the establishment of carrier status during horizontal infection but may not be primarily involved in the establishment of carrier status during perinatal infection. (HEPATOLOGY 1992; 15:382-386.) Patients with chronic HBV infection with high levels of HBV and HBeAg in serum can spontaneously lose HBeAg and develop anti-HBe, a seroconversion that usually proceeds a clinical and histological remission in disease (1-3). After seroconversion, most patients remain HBsAg+ with a low level or no detectable HBV. In contrast, loss of HBeAg and HBsAg rarely occurs in chronic HBV carriers. The annual rate of clearance of


📜 SIMILAR VOLUMES


Clinical course of spontaneous reactivat
✍ Philippe Levy; Dr. Patrick Marcellin; Michèle Martinot-Peignoux; Claude Degott; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB

The purposes of this study were (a) to describe the clinical and biochemical manifestations associated with spontaneous reactivation of hepatitis B virus as defined by the reappearance of hepatitis B virus DNA in serum using dot-blot hybridization and (b) to determine whether the clinical and bioche

δ-Infection and suppression of hepatitis
✍ Kim Krogsgaard; Peter Kryger; Jan Aldershvile; Poul Andersson; Thorkild I. A. Sø 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 1 views

The presence of hepatitis B virus DNA and anti-b was examined in a longitudinal study of 24 patients known to be &infected during the course from acute to chronic hepatitis B virus infection. Fifteen patients (63%) were hepatitis B virus DNA positive in the first serum sample. Eleven of 14 patients,

Spontaneous reactivation of hepatitis B
✍ Myron J. Tong; Richard E. Sampliner; Sugantha Govindarajan; Ruth L. Co 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 808 KB

## Eleven patients of Chinese origin experienced spontaneous reactivation of chronic active hepatitis B. Eight HBsAg-positive patients were followed for an average of 15 months prior to, while three others presented during reactivation. Fatigue, hepatomegaly and jaundice were frequent findings. El

Prevalence of hepatitis-C virus infectio
✍ Elisabeth Puchhammer-Stöckl; Hanns Hofmann; Franz Martin Fink; Wolfgang Mor; Son 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 1 views

## Abstract The prevalence of hepatitis‐C virus (HCV) infection was investigated in a group of children with chronic post‐transfusion hepatitis using a first‐and second‐generation HCV‐antibody ELISA, 2 confirmatory tests (a second‐generation recombinant immunoblot assay and a line immunoas‐say) as